Price range: $500.00 through $1,200.00
Repatha (evolocumab) is a medication used with other medicines to treat people with high blood cholesterol levels (hypercholesterolemia) and cardiovascular disease.
Disease Indications
Risk of cardiovascular events, Hypercholesterolemia
Manufacturer
Amgen Inc.
Usage
Subcutaneous
Medicine approved by
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Pharmaceuticals and Medical Devices Agency (PMDA)
| Package Pre-filled syringe/pen or cartridge | 2 prefilled autoinjector of 140 mg/mL, 6 prefilled autoinjector of 140 mg/mL, 1 infusor with 3 prefilled cartridge of 420 mg/3.5 mL |
|---|
Reviews
There are no reviews yet.